Skip to main content
. 2016 Apr 25;14(2):360–368. doi: 10.1111/iwj.12610

Table 2.

Distribution of RESVECH 2.0 items

RESVECH 2.0 n (%)
Depth/tissues involved
Dermis–epidermis involved 26 (76·5)
Subcutaneous tissue involved  8 (23·5)
Edges
Not distinguishable (not wound edges) 1 (2·9)
Diffuse  5 (14·7)
Delimited 20 (58·8)
Damaged  6 (17·6)
Thickened (‘aged’, ‘reverted’) 2 (5·9)
Wound dimensions
<4 cm2 16 (47·1)
4 ‐ < 16 cm2 15 (44·1)
16 ‐ < 36 cm2 2 (5·9)
64 ‐ < 100 cm2 1 (2·9)
Type of tissue in the wound bed
Epithelial tissue 2 (5·9)
Granulation tissue  7 (20·6)
Necrotic tissue and/or slough in the bed 25 (73·5)
Exudate
Moist 15 (44·1)
Wet 10 (29·4)
Saturated  5 (14·7)
Dry 2 (5·9)
Leaking exudate 2 (5·9)
Infection–inflammation (Biofilm signs)
Increasingly painful 21 (61·8)
Erythema around the wound 13 (38·2)
Oedema around the wound 13 (38·2)
Rising temperature  5 (14·7)
Increasing exudate 14 (41·2)
Purulent exudate  4 (11·8)
Tissue is friable or bleeds easily  8 (23·5)
Wound stationary, no progress 25 (73·5)
Tissue compatible with biofilm 12 (35·3)
Odour 10 (29·4)
Hipergranulation  8 (23·5)
Wound increasingly larger 10 (29·4)
Satellite lesions 11 (32·4)
Pale tissue 3 (8·8)